Glycomimetics are mimics of Carbohydrate Structure and function that act by replacing the natural ligands during recognition binding to the target protein. The design of glycomimetics enhances enzyme stability and bioavailability and increases affinity and selectivity for the target protein. At CD BioGlyco, our professional team of scientists manipulates the chemical information encoded by Marine Carbohydrates by adjusting (controlling and changing) the information they guide.
The design of marine carbohydrate mimetics is currently considered an effective alternative to developing therapeutic agents. We improve the properties of analogous drugs by starting with structural analysis of natural carbohydrate substrates bound to protein targets that stabilize their bioactive conformation and remove unwanted functional groups. The high-value conversion of marine carbohydrates mainly refers to its application in drugs, food, and cosmetics. Our scientists help you maximize the role of marine carbohydrates. Notably, we also provide high-targeting Drug-Delivery Vehicle, Vaccine, and Adjuvant development services based on marine carbohydrate.
Fig.1 Flowchart of marine carbohydrate mimetic development service. (CD BioGlyco)
With a special focus on the design and synthesis of carbohydrate mimics, CD BioGlyco provides a one-stop service for developing marine carbohydrate mimetics.
Sulfated fucan-based mimetics consist of sulfated L-fucose. It has a superior ability to induce platelet activation. CD BioGlyco provides sulfated fucan-based mimetic preparation and analysis services such as biparental nuclear replacement synthesis by using several technical routes.
Sulfated galactan-based mimetics contain variable sulfation patterns and 2,3-O-sulfated D-galactose residues. It has an anticoagulant and antithrombotic activity. CD BioGlyco offers comprehensive sulfated galactan-based mimetics development services from design and synthesis to drug applications.
CD BioGlyco has accurate synthesis strategies for heparin-based mimetic and provide clients with enzymatic elongation and chemical sulfation for modification. The mimetics such as di-, tri-, or tetrasaccharides. Furthermore, we evaluate the interaction of the mimetics with the receptor of higher glycation end products.
CD BioGlyco has a strategy for the design and synthesis of alginate-based mimetics with rich and diverse biological activities. It is formed by β-D-mannose and α-L-aldehyde acid through 1,4 linked glycosidic bonds. In addition, our professional analysis team provides follow-up analysis identification and drug development services.
Hyaluronic acid (HA) is a key element of the extracellular matrix (ECM). CD BioGlyco provides HA-based biomaterials as targeted delivery systems and ECM mimetics development services. In the presence of 2D and 3D models, we analyze HA particles as active targeting of drug/protein carriers.
Technology: Nuclear magnetic resonance, Electrospray ionization mass spectrometry
Journal: Communications Chemistry
IF: 6.681
Published: 2021
Results: A flexible and versatile diversity-oriented synthesis method was developed in this study. We used a one-pot-catalyzed aldehyde α-functionalization/aldol reaction to generate a series of stereochemically well-defined glycomimetic building blocks. These compounds have good yields and excellent diastereomer enantioselectivity. This simple method quickly and accurately generates large libraries of glycomimetics.
Fig.2 Synthesis of glycomimetics. (Meanwell, et al., 2021)
CD BioGlyco provides comprehensive Marine Biomolecule Production services to clients. We have an experienced technical team and diverse glycobiology platforms to meet the requirements of our clients. In addition, we offer professional Marine Carbohydrate-related Biomarker and Biomaterial Engineering Development services. Please feel free to .
References